Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India · Delayed Price · Currency is INR 750.00
-3.20 (-0.42%)
At close: Aug 21, 2026
BOM:544222 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 3,860 | 1,012 | 1,111 | 516.08 | 551.39 |
Short-Term Investments | - | 12,946 | 4,671 | 1,660 | 983.81 | 477.08 |
Cash & Short-Term Investments | 16,806 | 16,806 | 5,683 | 2,771 | 1,500 | 1,028 |
Cash Growth | 191.54% | 195.72% | 105.13% | 84.72% | 45.84% | 18.38% |
Accounts Receivable | - | 7,966 | 7,703 | 8,338 | 8,451 | 8,843 |
Other Receivables | - | - | - | - | 114.05 | - |
Receivables | - | 7,966 | 7,703 | 8,338 | 8,639 | 8,843 |
Inventory | - | 7,557 | 6,809 | 6,304 | 7,298 | 7,224 |
Prepaid Expenses | - | 188.44 | 164.55 | 127.11 | 90.96 | 79.42 |
Other Current Assets | - | 3,081 | 2,386 | 1,869 | 1,714 | 1,741 |
Total Current Assets | - | 35,599 | 22,746 | 19,409 | 19,242 | 18,916 |
Property, Plant & Equipment | - | 16,249 | 15,498 | 13,772 | 11,925 | 10,439 |
Long-Term Investments | - | 1.75 | 2.92 | 1.43 | 77.76 | 136.99 |
Goodwill | - | 20.63 | 20.63 | 20.63 | 20.63 | 20.63 |
Other Intangible Assets | - | 62.09 | 83.03 | 68.85 | 59 | 56.4 |
Long-Term Deferred Tax Assets | - | 1,709 | 2,081 | 1,231 | 315.17 | 188.53 |
Other Long-Term Assets | - | 828.5 | 703.16 | 660.96 | 1,026 | 877.71 |
Total Assets | - | 54,470 | 41,134 | 35,164 | 32,665 | 30,690 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 6,022 | 6,428 | 5,321 | 5,671 | 5,897 |
Accrued Expenses | - | 1,038 | 798.71 | 763.05 | 564.96 | 633.68 |
Short-Term Debt | - | 1,073 | 729.93 | 3,677 | 3,913 | 3,427 |
Current Portion of Long-Term Debt | - | - | - | 455.63 | 339.25 | 66.86 |
Current Portion of Leases | - | 76.33 | 72.3 | 57.65 | 72.41 | 66.22 |
Current Income Taxes Payable | - | 89.25 | 4.01 | 14.35 | 187.68 | 478 |
Current Unearned Revenue | - | 1,915 | 230.96 | 1.03 | 225.1 | - |
Other Current Liabilities | - | 735.25 | 673.71 | 1,816 | 1,682 | 2,155 |
Total Current Liabilities | - | 10,948 | 8,937 | 12,106 | 12,656 | 12,724 |
Long-Term Debt | - | - | - | 782.97 | 1,155 | 133.33 |
Long-Term Leases | - | 768.44 | 673.27 | 679.05 | 748.8 | 304.08 |
Long-Term Unearned Revenue | - | 8,408 | - | - | - | - |
Pension & Post-Retirement Benefits | - | 387.81 | 263.69 | 219.13 | 190.96 | 172.92 |
Long-Term Deferred Tax Liabilities | - | 177.06 | 186.16 | 121.54 | 253.01 | 392.98 |
Other Long-Term Liabilities | - | 469.5 | 437.72 | 14,051 | 10,428 | 10,711 |
Total Liabilities | - | 21,158 | 10,498 | 27,959 | 25,432 | 24,439 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 306.21 | 306.21 | 286.13 | 286.13 | 143.07 |
Additional Paid-In Capital | - | 10,942 | 10,840 | 1,272 | 1,272 | 1,272 |
Retained Earnings | - | 20,856 | 18,294 | 6,308 | 6,385 | 5,576 |
Comprehensive Income & Other | - | 1,030 | 1,030 | -771.26 | -771.26 | -771.26 |
Total Common Equity | 33,133 | 33,133 | 30,470 | 7,095 | 7,172 | 6,220 |
Minority Interest | - | 177.73 | 165.97 | 109.88 | 61.85 | 31.95 |
Shareholders' Equity | 33,311 | 33,311 | 30,636 | 7,205 | 7,234 | 6,252 |
Total Liabilities & Equity | - | 54,470 | 41,134 | 35,164 | 32,665 | 30,690 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1,917 | 1,917 | 1,476 | 5,652 | 6,229 | 3,998 |
Net Cash (Debt) | 14,889 | 14,889 | 4,208 | -2,882 | -4,729 | -2,969 |
Net Cash Growth | 247.13% | 253.85% | - | - | - | - |
Net Cash Per Share | 97.21 | 97.25 | 28.12 | -20.14 | -33.05 | -20.76 |
Filing Date Shares Outstanding | 153.15 | 153.1 | 153.1 | 147.36 | 143.06 | 143.06 |
Total Common Shares Outstanding | 153.15 | 153.1 | 153.1 | 143.06 | 143.06 | 143.06 |
Working Capital | - | 24,651 | 13,809 | 7,303 | 6,586 | 6,192 |
Book Value Per Share | 216.41 | 216.41 | 199.02 | 49.59 | 50.13 | 43.48 |
Tangible Book Value | 33,051 | 33,051 | 30,366 | 7,006 | 7,092 | 6,143 |
Tangible Book Value Per Share | 215.87 | 215.87 | 198.34 | 48.97 | 49.57 | 42.94 |
Land | - | 416.93 | 416.93 | 416.93 | 337.15 | 336.4 |
Buildings | - | 5,556 | 5,048 | 4,451 | 4,070 | 3,922 |
Machinery | - | 15,999 | 14,659 | 12,251 | 10,618 | 9,665 |
Construction In Progress | - | 1,767 | 1,596 | 1,951 | 1,030 | 308.19 |